How do the epitalon and NAD+ literatures differ on senescence endpoints?

The short answer

Answered from published research literature only. It describes what that literature examines; it is not a statement about use in people. Epitalon and NAD+ are investigational research material and are not approved products.

They measure different things. The epitalon record reports telomerase expression and telomere-biology endpoints in cell culture; the NAD+ record is biochemical characterisation of a redox coenzyme and its biosynthetic pathway.3201920440693873

Cellular senescence is a shared research-area tag rather than a shared measurement — neither record reports the other's endpoints.4014133340693873

Cited literature

1. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic MechanismKhavinson V, et al. · Molecules · 2020PMID 32019204 ↗
2. Characterization of the Nicotinamide Adenine Dinucleotide Biosynthesis Pathway and Regulatory Mechanisms in Streptococcus mutansYu H, et al. · The FASEB Journal · 2025PMID 40693873 ↗
3. Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising PropertiesAraj SK, et al. · International Journal of Molecular Sciences · 2025PMID 40141333 ↗

Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.

Where to read more

• Epitalon: identity and cited literature
• NAD+: identity and cited literature
• Epitalon product page
• NAD+ product page
• Epitalon certificate of analysis
• NAD+ certificate of analysis
• NAD+: the canine, equine literature, with its caveats